Onychomycosis and Bronchiolitis Therapeutics Clinical Trial Review H2 2014 Report at RnRMarketReserach.com
Dallas, TX (PRWEB) December 14, 2014 -- The clinical trial report “Onychomycosis and Bronchiolitis Global Clinical Trials Review H2 2014" provides data on the Onychomycosis and Bronchiolitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Onychomycosis and Bronchiolitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bronchiolitis.
Companies discussed in this Bronchiolitis Global Clinical Trials Review H2 2014 report include PARI GmbH, Merck & Co., Inc., Hamad Medical Corporation, ICDDR,B, GlaxoSmithKline plc, Fisher & Paykel Healthcare Corporation Limited, Bayer AG, APT Pharmaceuticals, Inc., Advanced Inhalation Therapies (AIT) Ltd. Complete Report on Bronchiolitis Global Clinical Trials Review H2 2014 is Available at http://www.rnrmarketresearch.com/bronchiolitis-global-clinical-trials-review-h2-2014-market-report.html.
Clinical Trial Overview of Top Institutes / Government include Baqiyatallah Medical Sciences University, Assistance Publique - Hopitaux de Paris, Connecticut Children's Medical Center, National Heart, Lung, and Blood Institute, Universitaire Ziekenhuizen Leuven, The Hospital for Sick Children, University of Edinburgh, University of Sao Paulo, Rambam Health Care Campus, Fred Hutchinson Cancer Research Center. Order a Purchase copy on Bronchiolitis Global Clinical Trials Review H2 2014 report at http://www.rnrmarketresearch.com/contacts/purchase?rname=249960.
Companies discussed in this Onychomycosis (Tinea Unguium) Global Clinical Trials Review H2 2014 report include GlaxoSmithKline plc, Anacor Pharmaceuticals, Inc., Novartis AG, Valeant Pharmaceuticals International, Inc., Moberg Pharma AB, Polichem S.A., Hisamitsu Pharmaceutical Co., Inc., Galderma S.A., Apricus Biosciences, Inc., Boehringer Ingelheim Auslandsbeteiligungs GmbH. Complete Report on Onychomycosis (Tinea Unguium) Global Clinical Trials Review H2 2014 is Available at http://www.rnrmarketresearch.com/onychomycosis-tinea-unguium-global-clinical-trials-review-h2-2014-market-report.html.
Clinical Trial Overview of Top Institutes / Government include Academia Espanola de Dermatologia y Venereologia, Homagama Base Hospital, Nanjing General Hospital of Nanjing Military Region, Malaga University, Vesale Hospital, Pasteur Institute of Iran, University of Tasmania, University of Brasilia, Rady Children's Hospital, Helsinki University Central Hospital. Order a Purchase copy on Onychomycosis Global Clinical Trials Review H2 2014 report at http://www.rnrmarketresearch.com/contacts/purchase?rname=249967.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
List of Tables in Onychomycosis Global Clinical Trials Review H2 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials by Region, 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, North America, Top Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Onychomycosis (Tinea Unguium) to Infectious Disease Clinical Trials, G7 Countries (%), 2014
Onychomycosis (Tinea Unguium) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Onychomycosis (Tinea Unguium) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Onychomycosis (Tinea Unguium) to Infectious Disease Clinical Trials, E7 Countries (%), 2014
Onychomycosis (Tinea Unguium) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Onychomycosis (Tinea Unguium) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials by Phase, 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Clinical Trials by Trial Status, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Onychomycosis (Tinea Unguium) Therapeutics, Global, Suspended Clinical Trials, 2014
Onychomycosis (Tinea Unguium) Therapeutics, Global, Terminated Clinical Trials, 2014
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Onychomycosis (Tinea Unguium) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Explore more reports on Clinical Trial industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial.
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article